Journal News

Researchers get to the bottom of noninvasive gut tests

Mucus contains vital data to help address diseases such as inflammatory bowel disease and colon cancer
David Bidwell
By David Bidwell
March 3, 2024

New research from the University of British Columbia Okanagan, recently published in the Journal of Biological Chemistry could make monitoring gut health easier and less painful by tapping into a common — yet often overlooked — source of information: the mucus in our digestive system that eventually becomes part of fecal matter.

Correct, what’s in our poop.

close-up of man holding his abdomen.
Liubomyr Vorona
New research from UBC Okanagan showed that noninvasive techniques can return vital gut health data from the mucus in our fecal matter.

Biology researcher Kirk Bergstrom and master’s student Noah Fancy found a noninvasive technique to study MUC2, a critical gut protein, from what we leave behind in the bathroom.

“MUC2 is like the silent star in our guts. It’s constantly working to protect us, and its proper functioning is crucial for our overall health,” Bergstrom said. “It was originally thought that you could only access this important molecule from biopsies or tissue removed via surgery — highly invasive and painful procedures.

“However, our study shows mucus is actually a part of our stool, meaning we can get at it painlessly and at levels we could not before. Anytime we can do analysis noninvasively, it’s a win.”

Clues to health can be found in unexpected places, and Bergstrom’s team found a way to study important gut health markers from fecal-adherent mucus — a term that, in simpler words, refers to the mucus attached to our stool. This mucus, typically ignored and flushed away, contains a trove of information about gut health.

MUC2, a glycoprotein with many sugar chains attached, forms a protective barrier in our intestines in the form of mucus, safeguarding our gut from harmful microbes and toxins and playing a crucial role in digestive health.

Understanding MUC2 better could lead to significant advancements in managing and preventing gut-related diseases, impacting the day-to-day well-being of millions.

“We can use these new methods to visualize mucus–microbiota interactions and how they go wrong in various diseases, like inflammatory bowel diseases and colon cancer,” Bergstrom noted.  “The sugars on the mucins also carry lots of information on the health status of the colon.”

Fancy led the work, which was the result of a strong collaborative effort between the Bergstrom Lab and the chemistry lab of Wesley Zandberg and the biology labs of Sepideh Pakpour, Deanna Gibson and Sanjoy Ghosh, all at UBC Okanagan.

This article was originally published in the UBC Okanagan News. You can read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
David Bidwell
David Bidwell

David Bidwell is a writer and content strategist, University Relations, University of British Columbia Okanagan.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The molecular orchestra of memory
Feature

The molecular orchestra of memory

April 16, 2026

Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.